DK0868174T3 - Oral gelkapselformulering af 1,2,4-benzotriazinoxider - Google Patents

Oral gelkapselformulering af 1,2,4-benzotriazinoxider

Info

Publication number
DK0868174T3
DK0868174T3 DK96928255T DK96928255T DK0868174T3 DK 0868174 T3 DK0868174 T3 DK 0868174T3 DK 96928255 T DK96928255 T DK 96928255T DK 96928255 T DK96928255 T DK 96928255T DK 0868174 T3 DK0868174 T3 DK 0868174T3
Authority
DK
Denmark
Prior art keywords
capsule formulation
gel capsule
oral gel
benzotriazine oxides
benzotriazine
Prior art date
Application number
DK96928255T
Other languages
Danish (da)
English (en)
Inventor
Stephen Brown
Ross Blundell
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Application granted granted Critical
Publication of DK0868174T3 publication Critical patent/DK0868174T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96928255T 1995-09-12 1996-08-21 Oral gelkapselformulering af 1,2,4-benzotriazinoxider DK0868174T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/527,233 US5597582A (en) 1995-09-12 1995-09-12 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
PCT/US1996/013517 WO1997009968A1 (fr) 1995-09-12 1996-08-21 Formulation d'oxydes de 1, 2, 4-benzotriazine pour capsules de gel orales

Publications (1)

Publication Number Publication Date
DK0868174T3 true DK0868174T3 (da) 2003-03-17

Family

ID=24100665

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96928255T DK0868174T3 (da) 1995-09-12 1996-08-21 Oral gelkapselformulering af 1,2,4-benzotriazinoxider

Country Status (19)

Country Link
US (1) US5597582A (fr)
EP (1) EP0868174B1 (fr)
JP (1) JPH11513365A (fr)
KR (1) KR100475388B1 (fr)
CN (1) CN1080113C (fr)
AT (1) ATE227982T1 (fr)
AU (1) AU702550B2 (fr)
CA (1) CA2231545C (fr)
CZ (1) CZ289733B6 (fr)
DE (1) DE69624935T2 (fr)
DK (1) DK0868174T3 (fr)
ES (1) ES2187668T3 (fr)
HK (1) HK1016889A1 (fr)
HU (1) HUP9802605A3 (fr)
MX (1) MX9801930A (fr)
NO (1) NO320019B1 (fr)
NZ (1) NZ315964A (fr)
PT (1) PT868174E (fr)
WO (1) WO1997009968A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
CA2456569A1 (fr) * 2003-03-14 2004-09-14 Auckland Uniservices Limited Mono-n-oxides de benzoazine et 1,4-dioxides de benzoazine et compositions a base de ceux-ci pour usage therapeutique dans les traitements de cancers
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
CN1950071A (zh) * 2004-05-04 2007-04-18 霍尔莫斯医疗有限公司 ospemifene的新口服制剂
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
CN104705772B (zh) * 2015-01-28 2016-09-14 汤臣倍健股份有限公司 一种改善软胶囊漏油的生产工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US5175287A (en) * 1986-09-25 1992-12-29 S R I International Process for preparing 1,2,4-benzotriazine oxides
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
WO1996037192A1 (fr) * 1995-05-26 1996-11-28 Vesifact Ag Compositions pharmaceutiques et cosmetiques contenant des sphingolipides et des glycolipides
US5637085A (en) * 1995-11-20 1997-06-10 Cardinale; Robert M. Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site

Also Published As

Publication number Publication date
CN1080113C (zh) 2002-03-06
NZ315964A (en) 1999-03-29
NO981042D0 (no) 1998-03-10
NO320019B1 (no) 2005-10-10
CZ64498A3 (cs) 1998-08-12
EP0868174A4 (fr) 1998-10-07
DE69624935T2 (de) 2003-03-27
KR100475388B1 (ko) 2005-08-05
PT868174E (pt) 2003-04-30
CN1200669A (zh) 1998-12-02
US5597582A (en) 1997-01-28
EP0868174A1 (fr) 1998-10-07
CZ289733B6 (cs) 2002-03-13
HUP9802605A3 (en) 2000-02-28
WO1997009968A1 (fr) 1997-03-20
EP0868174B1 (fr) 2002-11-20
AU6780096A (en) 1997-04-01
MX9801930A (es) 1998-10-31
DE69624935D1 (de) 2003-01-02
NO981042L (no) 1998-03-10
CA2231545A1 (fr) 1997-03-20
CA2231545C (fr) 2008-07-15
JPH11513365A (ja) 1999-11-16
ES2187668T3 (es) 2003-06-16
KR19990044573A (ko) 1999-06-25
ATE227982T1 (de) 2002-12-15
HK1016889A1 (en) 1999-11-12
AU702550B2 (en) 1999-02-25
HUP9802605A2 (hu) 1999-04-28

Similar Documents

Publication Publication Date Title
DE68905224D1 (de) Transendoskopische implantatkapsel.
CA2109623A1 (fr) Procede de solubilisation de substances pharmaceutiquement actives peu solubles
DE69525019T2 (de) Cyclosporin enthaltende Weichkapselzusammensetzungen
KR960702304A (ko) 고용량 제형 (High dose formulations)
CA2310585A1 (fr) Nouvelle forme galenique comprenant un compose actif acido-labile
ZA9511034B (en) Soft gelatin pharmaceutical dosage form
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
DE69425859D1 (de) Cyclosporin enthaltende Weichkapsel
DE69711267D1 (de) Cyclosporin enthaltende Weichkapselpräparate
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
DK0868174T3 (da) Oral gelkapselformulering af 1,2,4-benzotriazinoxider
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
NO980296L (no) Forbedrede terapeutiske midler
DE68906245D1 (de) Therapeutisches mittel gegen aids.
DE9414607U1 (de) Parfümkapsel
DE68910125D1 (de) Oral-Präparate.
IL131703A0 (en) Pharmaceutical compositions in the form of soft gelatine capsule containing cyclosporin
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
KR920007598U (ko) 의약용 캅셀
MX9203494A (es) Fenilhidrazonas, la elaboracion de las mismas y composiciones terapeuticas y cosmeticas preparadas a partir de las mismas.
IT213788Z2 (it) Elmetto ad elevata protezione di alta confortevolezza.
DE58902121D1 (de) Weichgelatinekapsel.
IT8719246A0 (it) Procedimento di costruzione di un'isola artificiale, mezzi atti a realizzare detto procedimento e manufatto cosi' ottenuto.